Bioavailability and Pharmacokinetics of Lorazepam after Intranasal, Intravenous, and Intramuscular Administration
β Scribed by Wermeling, Daniel Paul H.; Miller, Jodi Lynn; Archer, Sanford Mitchell; Manaligod, Jose M.; Rudy, Anita C.
- Book ID
- 121862541
- Publisher
- Sage Publications
- Year
- 2001
- Tongue
- English
- Weight
- 88 KB
- Volume
- 41
- Category
- Article
- ISSN
- 0091-2700
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Dichlorazepate (DPC) was given to eight healthy volunteers aged 22-38 years (five males and three females). The dose was 20 mg (48.9 gmol) given either as an IV or an IM injection. The interval between the injections was at least 1 week. Plasma samples were analysed for desmethyldiazepam (DMD) by HP
Ten healthy volunteers received single 2-mg doses of lorazepam on five occasions in random sequence. Modes of administration were: A, intravenous injection; B, deltoid intramuscular injection; C, oral tablets in the fasting state; D, sublingual dosage of oral tablets in the fasting state; and E, sub